文献速递主动脉疾病内脏/肾动脉与血管畸形

胸主动脉腔内修复术中腹腔干覆盖的系统综述与Meta分析

Coverage of the Coeliac Artery During Thoracic Endovascular Aortic Repair: A Systematic Review and Meta-Analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2022-02-25

该系统综述与Meta分析检索1989至2020年文献,纳入15项观察性研究共236例患者,评估胸主动脉腔内修复术中覆盖腹腔干的临床影响。结果显示内脏缺血率13%、脊髓缺血率5%、30天/住院死亡率4%、内漏率21%、再干预率13%。作者认为应尽可能避免覆盖腹腔干。

要点

  • 覆盖腹腔干的胸主动脉腔内修复术内脏缺血发生率为13%,异质性显著。
  • 脊髓缺血率5%、30天/住院死亡率4%、再干预率13%,证据确定性极低。
  • 作者认为胸主动脉腔内修复术中应尽可能避免覆盖腹腔干。

核心结论

  • 胸主动脉腔内修复术中覆盖腹腔干与较高的内脏缺血、脊髓缺血、30天/住院死亡率、内漏和再干预率相关。
  • 尽管文献质量差且效应估计仍存疑问,有证据表明胸主动脉腔内修复术中应尽可能避免覆盖腹腔干。

研究设计与样本

  • 系统综述与Meta分析,按照PRISMA指南进行,检索1989至2020年电子数据库。
  • 纳入15项观察性研究,共236例患者(108例男性,年龄范围61.3至79岁)。
  • 采用随机效应模型进行Meta分析,使用GRADE方法对证据质量进行分级。
  • PROSPERO注册号244084。

主要发现

  • 合并内脏缺血率为13%(95%CI 4至24;I²=72%,P<.001),研究间异质性显著。
  • 脊髓缺血率为5%(95%CI 2至9;I²=0%)。
  • 30天/住院死亡率为4%(95%CI 1至7;I²=0%)。
  • 总体内漏率为21%(95%CI 13至29;I²=35%),其中Ib型内漏率5%(95%CI 0至13;I²=38%),因腹腔干逆行血流导致的II型内漏率2%(95%CI 0至8;I²=43%)。
  • 再干预率为13%(95%CI 6至22;I²=54%), caudal支架移植物移位率为3%(95%CI 0至9;I²=0%)。

关键数值与推荐

  • 所有结局的证据体确定性均判定为极低。

临床怎么用

  • 作者认为胸主动脉腔内修复术中应尽可能避免覆盖腹腔干。

局限性

  • 文献质量差。
  • 效应估计仍存疑问。
  • 所有结局的证据体确定性均判定为极低。
  • 内脏缺血率存在显著异质性(I²=72%,P<.001)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the clinical impact of coeliac artery (CA) coverage during thoracic endovascular aortic repair (TEVAR). METHODS: This systematic review and meta-analysis was conducted according to the PRISMA guidelines. Electronic databases were searched from 1989 to 2020 for studies reporting visceral ischaemia, spinal cord ischaemia (SCI), 30 day/in hospital mortality, endoleaks, re-intervention, and caudal stent graft migration following CA coverage in patients undergoing TEVAR. Meta-analysis was conducted using random effects modelling. The quality of the evidence was graded using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) approach. RESULTS: Fifteen observational studies with 236 patients (108 male, age range 61.3 - 79 years) were included. The pooled visceral ischaemia rate was 13% with significant heterogeneity between studies (95% confidence intervals [CI] 4 - 24; I2 = 72%, p < .001). The SCI rate was 5% (95% CI 2 - 9; I2 = 0%); the 30 day/in hospital mortality was 4% (95% CI 1 - 7; I2 = 0%); the overall endoleak rate was 21% (95% CI 13 - 29; I2 = 35%) with a 5% (95% CI 0 - 13; I2 = 38%) rate of type Ib and 2% (95% CI 0 - 8; I2 = 43%) rate of type II endoleak from retrograde CA flow. The re-intervention rate was 13% (95% CI 6 - 22; I2 = 54%); the caudal stent graft migration rate was 3% (95% CI 0 - 9, I2 = 0%). The certainty of the body of evidence was judged to be very low for all outcomes. CONCLUSION: CA coverage during TEVAR is associated with high rates of visceral ischaemia, spinal cord ischaemia, 30 day/in hospital mortality, endoleaks, and re-intervention. Although the literature is of poor quality and questions remain over effects estimates, there is evidence that CA coverage should be avoided if at all possible, during TEVAR. REGISTRATION: PROSPERO registration number 244084.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Hanna L, Lam K, Agbeko AE, et al. Coverage of the Coeliac Artery During Thoracic Endovascular Aortic Repair: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg. 2022. PMID: 35460890. doi:10.1016/j.ejvs.2022.02.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。